Source: Targeted Oncology
Moffitt Cancer Center has been awarded a National Cancer Institute (NCI) Specialized Programs of Research Excellence (SPORE) grant for skin cancer research. The grant totals $8,829,020 over five years and will fund three projects aimed at improving melanoma treatment and outcomes. This is Moffitt's second SPORE grant. The first, a SPORE for lung cancer research, was awarded in 2008. Moffitt is the only cancer center in Florida that has received this prestigious grant. "SPORE grants were established to promote interdisciplinary research and move basic findings from the laboratory to a clinical setting. The addition of a melanoma SPORE acknowledges our collaborative bench-to-bedside approach and translational research in the area of skin cancer," said Jeffrey S. Weber, MD, PhD, director Moffitt's Donald A. Adam Comprehensive Melanoma Research Center of Excellence.
The SPORE grant has been several years in the making. In 2007, Moffitt was awarded a melanoma SPORE planning grant from Florida's Bankhead-Coley Cancer Research Program to help recruit a team of interdisciplinary skin cancer researchers. That same year, Donald A. Adam, a melanoma survivor and banker, donated $20.4 million to Moffitt for expanding expertise in the area of melanoma research. The gift led to the development of the Donald A. Adam Comprehensive Melanoma Research Center of Excellence.
Learn more about what differentiates Moffitt by visiting MOFFITT.org/MD